ALESSIO, ENZO
 Distribuzione geografica
Continente #
NA - Nord America 17.689
EU - Europa 10.962
AS - Asia 2.220
AF - Africa 58
SA - Sud America 41
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 17
Totale 31.013
Nazione #
US - Stati Uniti d'America 17.592
DE - Germania 2.610
SE - Svezia 1.752
UA - Ucraina 1.599
IT - Italia 1.349
GB - Regno Unito 849
CN - Cina 833
RU - Federazione Russa 737
TR - Turchia 547
PL - Polonia 511
FI - Finlandia 501
HK - Hong Kong 483
BG - Bulgaria 293
IE - Irlanda 280
FR - Francia 176
SG - Singapore 132
IN - India 92
CA - Canada 85
CH - Svizzera 81
SN - Senegal 34
BE - Belgio 33
NL - Olanda 32
ES - Italia 30
EU - Europa 26
VN - Vietnam 21
BR - Brasile 20
RO - Romania 20
GR - Grecia 17
ID - Indonesia 17
CZ - Repubblica Ceca 16
JP - Giappone 15
AT - Austria 14
PT - Portogallo 14
RS - Serbia 14
SA - Arabia Saudita 13
EG - Egitto 11
AU - Australia 10
IR - Iran 10
MX - Messico 10
AR - Argentina 8
CL - Cile 7
HU - Ungheria 7
JO - Giordania 7
NZ - Nuova Zelanda 7
GE - Georgia 6
ZA - Sudafrica 6
IL - Israele 5
KR - Corea 5
SK - Slovacchia (Repubblica Slovacca) 5
BD - Bangladesh 4
LT - Lituania 4
MY - Malesia 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
HR - Croazia 3
IQ - Iraq 3
LK - Sri Lanka 3
PH - Filippine 3
SI - Slovenia 3
TH - Thailandia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
CO - Colombia 2
GH - Ghana 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
PK - Pakistan 2
QA - Qatar 2
TW - Taiwan 2
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
IM - Isola di Man 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
Totale 31.013
Città #
Woodbridge 2.445
Ann Arbor 2.387
Fairfield 1.927
Houston 1.787
Jacksonville 1.414
Chandler 1.142
Wilmington 1.044
Ashburn 932
Seattle 787
Cambridge 650
Princeton 529
Izmir 499
Warsaw 490
Hong Kong 473
Sofia 292
Beijing 287
Dublin 273
Trieste 267
Dearborn 222
Boardman 197
Milan 141
San Diego 126
Munich 101
Singapore 80
Redwood City 75
Verona 71
Bern 70
Mcallen 67
Düsseldorf 57
Hefei 55
Chicago 53
Buffalo 52
Mestre 49
Montréal 48
Nanjing 48
Des Moines 46
Phoenix 39
Norwalk 37
Kunming 35
Dakar 34
Kocaeli 34
Guangzhou 32
Helsinki 28
Brussels 27
Bremen 23
Andover 20
Los Angeles 20
Jinan 19
Nanchang 19
Ottawa 17
Rome 17
Shanghai 17
Zhengzhou 16
Falls Church 15
Wuhan 15
Chengdu 14
Costa Mesa 12
Washington 12
Edinburgh 11
Fuzhou 11
Hebei 11
Lisbon 11
Sacile 11
Shenyang 11
Venezia 11
Athens 10
Auburn Hills 10
Bengaluru 10
Brno 10
Dagenham 10
Dong Ket 10
Vienna 10
Zurich 10
Florence 9
Fremont 9
Hanoi 9
Redmond 9
Torre Del Greco 9
Aachen 8
Baotou 8
Chennai 8
Erlangen 8
Polska 8
Udine 8
Berlin 7
London 7
Toronto 7
Amsterdam 6
Barcelona 6
Bari 6
Belgrade 6
Bologna 6
Changsha 6
Dongguan 6
Indiana 6
Leawood 6
Madrid 6
New Delhi 6
New York 6
Padova 6
Totale 20.034
Nome #
Neutral 1,3,5-Triaza-7-phosphaadamantane-Ruthenium(II) Complexes as Precursors for the Preparation of Highly Water-Soluble Derivatives 524
Chimica Inorganica, seconda edizione italiana condotta sulla quinta edizione inglese 443
New Insight into a Deceptively Simple Reaction: The Coordination of bpy to RuII-Carbonyl Precursors - The Central Role of thefac-[Ru(bpy)Cl(CO)3]+Intermediate and theChloride Rebound Mechanism 328
New Cationic and Neutral Ru(II)- and Os(II)-dmso carbonyl Compounds 299
1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for thepreparation of ruthenium complexes with potential anticancer activity 258
null 252
Side-to-face ruthenium porphyrin arrays. Photophysical behavior of dimeric and pentameric systems. 246
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective 226
A noncovalently linked, dynamic fullerene porphyrin dyad. Efficient formation of long-lived charge separated states through complex dissociation. 207
New salts of anionic complexes of Ru(III) as antimetastatic and antineoplastic agents. 200
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry 196
Synthesis, Molecular Structure and Chemical Behavior of Hydrogen trans-bis(Dimethylsulfoxide)Tetrachlororuthenate(III) and mer-Trichlorotris(Dimethylsulfoxide)Ruthenium(III) - the First Fully Characterized Chloride Dimethylsulfoxide Ruthenium(III) Complexes 194
Palladium complexes with simple iminopyridines as catalysts for polyketone synthesis 188
The synthesis of RuBr2(DMSO)3 revisited: a mixture of Li[fac-RuClnBr3-n(DMSO)3] isomers (n = 0-3) is the reaction product 181
New atropisomeric bidentate nitrogen-donor compounds as potential stereocontrollers in mild CO-styrene copolymerisation catalysed by palladium(II) salts. 179
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 179
Synthesis and characterization of new halogen -tetramethylene sulfoxide-ruthenium(II) and ruthenium(III) complexes; crystal structure of cis-dichlorotetrakis(tetramethylene sulfoxide) ruthenium(II) and hydrogen trans-bis(tetramethylene sulfoxide)tetrachlororuthenate(III) 177
Sulfoxide ruthenium complexes: non toxic tools for the selective treatment of solid tumour metastases. 177
Solution and solid state structure of a canted, side-to-face, bis-porphyrin adduct. 176
Design of photoactivatable metallodrugs: Selective and rapid light-induced ligand dissociation from half-sandwich [Ru([9]aneS3)(N–N′)(py)]2+ complexes 176
Discrete Supramolecular Assemblies of Porphyrins Mediated by Coordination Compounds 173
Synthesis and Properties of Novel Fullerene Derivatives 170
Reduction of lung metastases by Na[trans-RuCl4(DMSO)Im] is not coupled with the induction of chemical xenogenization 167
Activation of Rh6(CO)16 with 1,10-phenanthroline and substituted derivatives in the catalytic reduction of nitrobenzene to aniline with carbon monoxide and water 167
Chemical properties of rare platinum metal complexes having antitumor activity 167
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 164
The rare head-to-head conformation of untethered lopsided ligands discovered in both solution and solid states of 1,5,6-trimethylbenzimidazole Re(V) and Ru(II) complexes. 163
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity. 162
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 160
Synthesis and characterization of a new series of palladium(II) compounds with nitrogen-donor chelating ligands: [Pd(chel)(L)2][PF6]2 159
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 158
(15)N NMR spectroscopy unambiguously establishes the coordination mode of the diimine linker 2-(2'-pyridyl)pyrimidine-4-carboxylic acid (cppH) in Ru(II) complexes 158
Crystals containing conformers: a rare case in which a solid closely reflects a solution equilibrium mixture 157
Two-point self-coordination of a dizinc(ii) bis-pyridylporphyrin ruthenium complex leading selectively to a discrete molecular assembly: solution and solid state characterization 156
Ruthenium anticancer compounds: challenges and expectations 155
Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity 155
Ruthenium(III) complexes as antineoplastic agents. 154
A novel open-box shaped pentamer of vertically linked porphyrins that selectively recognizes S-bonded Me2SO complexes. 154
Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media 154
NMR structural characterization of the reaction product between d(GpG) and the octahedral antitumor complex trans-RuCl2(DMSO)4. 154
Carbonyl derivatives of chloride dimethyl-sulfoxide ruthenium(II) complexes. Synthesis, structural characterization, and reactivity of Ru(CO)(X)(Dmso)(4-X)Cl-2 complexes (X=1-3) 154
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 153
Wavelength-Dependent Electron and Energy Transfer Pathways in a Side-to-Face Ruthenium Porphyrin / Perylene Bisimide Assembly 152
The interaction of the antitumor complexes Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)] with apotransferrin: a spectroscopic study 152
Photolabile Ru Model Complexes with Chelating Diimine Ligands for Light-Triggered Drug Release 152
Porphyrin "flying saucers": Solid state and solution structure of a novelpentameric array of axially-ligated canted porphyrins. 150
Activation of carbonyl clusters with 1,10-phenanthroline and related ligands: the reduction of nitrobenzene as a model reac¬tion for MX(CO)Y (M = Ru, Os, Ir) + Phen systems as catalyst precursors 150
Complessi trans di rutenio come agenti antineoplastici 148
Energy Transfer Pathways in Pyridylporphyrin Re(I) Adducts. 148
Factors that influence the antiproliferative activity of half sandwich RuII-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives. 148
A spectroscopic study of the reaction of NAMI, a novel ruthenium(III) anti-neoplastic complex, with bovine serum albumin 147
Geometrical and linkage isomers of OsCl2(dmso)4: the complete picture 147
Complessi dicarbossilati del rutenio(II) e loro impiego come antitumorali 146
Structure of trans-dichlorotetrakis(dimethyl sulfoxide)rhodium(III) tetrafluoroborate 146
Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: the crystal structure of [ImH][trans-RhCl4(Im)2] (Im= imidazole) 146
Selective hydrogen transfer reactions from alcohols to ketones promoted by rhodium complexes with 1,10-phenanthroline and related ligands 146
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 145
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 145
Towards Matched Pairs of Porphyrin-ReI/99mTcIConjugates that Combine Photodynamic Activity with Fluorescence and Radio Imaging 145
Synthesis, structural characterization and chemical behavior of new dimeric Ru(III) complexes 143
The Deceptively Similar Ruthenium(III) Drug Candidates KP1019 and NAMI-A Have Different Actions. What Did We Learn in the Past 30 Years? 142
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 141
Mixed-ligand rhenium(V) oxo monomers with triphenylphosphine oxide and lopsided and symmetrical heterocyclic ligands. Putative intermediates in rhenium(V) oxo synthetic chemistry 141
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 141
New aspects of Rh(III)-dimethyl sulfoxide chemistry: synthesis and molecular structure of [NEt4][cis-RhCl4(DMSO)2] and chemical behaviour in aqueous solution of [RhCln(DMSO)6-n](3-n) (n = 3, 4) complexes. 140
Ruthenium-Porphyrin Conjugates with Cytotoxic and Phototoxic Antitumor Activity 140
Bioinorganic Medicinal Chemistry 140
Water-Soluble Ruthenium(II) Carbonyls with 1,3,5-Triaza-7-phosphoadamantane 140
Steric properties of sulfoxide ligands. Synthesis and crystal-structure of mer-[RuCl3(Ph(2)SO)3] 139
A categorization of metal anticancer compounds based on their mode of action. 138
Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties 138
Rare Example of Stereoisomeric 2 + 2 Metallacycles of Porphyrins Featuring Chiral-at-Metal Octahedral Ruthenium Corners 138
Is the aromatic fragment of piano-stool ruthenium compounds an essential feature for anticancer activity? The development of new Ru(II)-[9]aneS3 analogues. 137
Electronic Energy Transfer in a Multiporphyrin-based Molecular Box 137
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 136
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 136
Carbonyl derivatives of chloride-dimethyl sulfoxide-ruthenium(III) complexes. Synthesis, crystal-structure, and reactivity of [(Dmso)(2)H][Trans-RuCl4(Dmso)(CO)] and mer, cis-RuCl3(Dmso)(2)(CO) 136
Metallacycles of Porphyrins as Building Blocks in the Construction of Higher Order Assemblies through Axial Coordination of Bridging Ligands: Solution- and Solid-State Characterization of Molecular Sandwiches and Molecular Wires 136
Comparison of the effects of the antimetastatic compound ImH[trans-RuCl4(DMSO)Im] (NAMI-A) on the arthritic rat and on MCa mammary carcinoma in mice 136
Ordered supramolecular porphyrin arrays from a building block approach utilizing pyridylporphyrins and peripheral ruthenium complexes and identification of a new type of mixed-metal building block 135
Synthesis and Reactivity of Ru-, Os-, Rh-, and Ir-halide-sulfoxide Complexes. 135
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 134
The first example of a double bridged diruthenium(II) complex containing the rare bridging S,O bidentate dimethyl sulfoxide ligand which defines a stable Ru-Cl-Ru-S-O five-membered ring. 134
Novel Ruthenium Building Blocks for the Efficient Modular Construction of Heterobimetallic Molecular Squares of Porphyrins 134
Synthesis and crystal structure of new Ru(III)-sulfoxide complexes containing a planar N-ligand: mer,cis-RuCl3(1Me-Im)(2)(S-DMSO) and [4Et-PyH][trans-RuCl4(4Et-Py)(S-DMSO)] 134
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors 134
New Uses for Old Drugs: Attempts to Convert Quinolone Antibacterials into Potential Anticancer Agents Containing Ruthenium 134
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy 134
New geometrical and linkage isomers of the Ru(II) precursor cis,cis,trans-RuCl2(dmso-S)2(dmso-O)(CO): a spectroscopic and structural investigation 133
New Water-Soluble Ruthenium(II) Terpyridine Complexes for Anticancer Activity: Synthesis, Characterization, Activation Kinetics, and Interaction with Guanine Derivatives 133
Novel diastereoisomers with opposite chirality at ruthenium formed by N7,alfa-PO4 chelation of 5'-dGMP to the antimetastatic agent, trans-RuCl2(DMSO)4: NMR and CD evidence. 132
C60 in the Box. A Supramolecular C60 - Porphyrin Assembly 131
Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an antimetastatic ruthenium complex 131
Synthesis and Characterization of Two New Classes of Ruthenium(III-Sulfoxide Complexes with Nitrogen Donor Ligands (L) - {$Na\left[\mathit{trans}-RuCl_4(R_2SO)(L)\right]$} and {$\mathit{mer,cis}-RuCl_3(R_2SO)(R_2SO)(L)$} - the crystal structure of {$Na\left[\mathit{trans}-RuCl_4(DMSO)(NH_3)\right]\cdot{}2DMSO$}, {$Na\left[\mathit{trans}-RuCl_4(DMSO)(Im)\right]\cdot{}{H_2O},{Me_2CO}$} (Im=Imidazole) and {$\mathit{mer,cis}-RuCl_3(DMSO)(DMSO)(NH_3)$} 131
Synthetic Strategies and Structural Aspects of Metal-Mediated Multi-Porphyrin Assemblies 130
Metal-mediated multi-porphyrin discrete assemblies and their photoinduced properties. 130
Pyridylporphyrin metallacycles with a slipped cofacial geometry: spectroscopic, X-ray and photophysical characterization. 130
Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines. 130
Stepwise Assembly of Unsymmetrical Supramolecular Arrays Containing Porphyrins and Coordination Compounds. 129
Rhodium(III) analogs of antitumor active ruthenium(III) compounds. The crystal structure of [ImH][trans-RhCl4(Im)2] (Im = imidazole) 129
Totale 16.385
Categoria #
all - tutte 75.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019553 0 0 0 0 0 0 0 0 0 0 0 553
2019/20206.740 349 359 390 1.182 491 881 661 809 554 377 556 131
2020/20214.414 475 272 486 652 274 456 267 361 176 409 156 430
2021/20223.163 146 235 197 422 70 225 94 126 358 300 215 775
2022/20233.668 376 439 267 442 437 695 32 290 435 24 170 61
2023/20241.853 173 139 93 166 197 107 206 503 15 33 173 48
Totale 31.847